10-62813496-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000399.5(EGR2):c.1142G>A(p.Arg381His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R381L) has been classified as Pathogenic.
Frequency
Consequence
NM_000399.5 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 4EInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
- Charcot-Marie-Tooth diseaseInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 1DInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease type 3Inheritance: SD, AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000399.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EGR2 | NM_000399.5 | MANE Select | c.1142G>A | p.Arg381His | missense | Exon 2 of 2 | NP_000390.2 | ||
| EGR2 | NM_001410931.1 | c.1181G>A | p.Arg394His | missense | Exon 3 of 3 | NP_001397860.1 | |||
| EGR2 | NM_001136177.3 | c.1142G>A | p.Arg381His | missense | Exon 3 of 3 | NP_001129649.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EGR2 | ENST00000242480.4 | TSL:1 MANE Select | c.1142G>A | p.Arg381His | missense | Exon 2 of 2 | ENSP00000242480.3 | ||
| EGR2 | ENST00000439032.6 | TSL:1 | n.*1157G>A | non_coding_transcript_exon | Exon 2 of 2 | ENSP00000509775.1 | |||
| EGR2 | ENST00000439032.6 | TSL:1 | n.*1157G>A | 3_prime_UTR | Exon 2 of 2 | ENSP00000509775.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 1D Pathogenic:1Uncertain:1Other:1
not provided Pathogenic:2
This variant was not reported in large, multi-ethnic, general populations (http://gnomad.broadinstitute.org). This variant appears to occur de novo in multiple individuals with clinical features associated with this gene. Assessment of experimental evidence suggests this variant results in abnormal protein function. Multiple studies have shown that this variant results in the loss of transcriptional regulatory activity required for normal myelination (PMID: 11734543, 12609493).
EGR2: PM1, PM2, PM5, PM6, PS4:Moderate, PS3:Supporting
Charcot-Marie-Tooth disease Uncertain:2
Charcot-Marie-Tooth disease, type I Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 381 of the EGR2 protein (p.Arg381His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Charcot-Marie-Tooth (CMT) (PMID: 10762521, 12471219, 22765307, 25720245). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 41008). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EGR2 protein function. Experimental studies have shown that this missense change affects EGR2 function (PMID: 12609493). This variant disrupts the p.Arg381 amino acid residue in EGR2. Other variant(s) that disrupt this residue have been observed in individuals with EGR2-related conditions (PMID: 11239949, 20513111), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at